TORONTO, ONTARIO--(Marketwire - May 13, 2008) - Attention: Business/Financial Editors: The Medipattern Corporation (“Medipattern”) (TSX VENTURE: MKI), an award-winning developer of computer-aided detection (CAD) medical imaging software designed to aid physicians in making better informed biopsy decisions and to permit a higher standard of care for the millions of patients at risk of breast cancer, today announced its business highlights and unaudited financial results for the third quarter and nine-months ended March 31, 2008.
